Curis | CRIS - Чистый доход





Чистый доход Изменить Дата
Alaunos Therapeutics USD -1.01M 153K 2026-03
Amgen USD 2.38B 556M 2026-06
AstraZeneca USD 2.51B 573M 2026-06
Bayer EUR 219M 2.54B 2026-06
Bristol-Myers Squibb USD 3.32B 640M 2026-06
CSL USD 401M 96.5M 2025-12
Curis USD -24.2M 43.56M 2026-03
Eli Lilly USD 7.1B 301M 2026-06
Exelixis USD 212.05M 1.58M 2026-06
Gilead Sciences USD -10.5B 12.52B 2026-06
GlaxoSmithKline GBP 435M 1.3B 2026-06
Incyte USD 585.6M 282.27M 2026-06
Merck USD -1.34B 2.9B 2026-06
Novartis USD 3.26B 108M 2026-06
Pfizer USD -248M 2.94B 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Sanofi EUR 343M 1.27B 2026-06
Takeda JPY 113.2B 137.52B 2026-06
TG Therapeutics USD 7.78M 12M 2026-06
Verastem USD -36.59M 3.68M 2026-03